Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,434Revenue $M358Net Margin (%)-21.5Altman Z-Score3.7
Enterprise Value $M5,479EPS $-0.8Operating Margin %-1.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.3Pre-tax Margin (%)-22.3Higher ROA y-yY
Price/Book6.810-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsY
Price/Sales9.75-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-8.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-24.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M155ROIC % (ttm)8.3Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2015-03-31 Sold Out -0.011%$12.8 - $25.97
($18.33)
$ 35.1792%Sold Out0
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 35.17181%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 35.17205%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 35.17147%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-07-15Sell26,887$35.55-1.07view
Himawan JeffDirector 2015-03-13Sell554,564$22.4456.73view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.8560.96view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.05191.87view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.05191.87view
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.05191.87view
Nohria VirinderDirector 2014-11-13Sell1,739,130$11.54204.77view
VENKATARAMAN BALAJIFormer 10% Owner 2014-11-13Sell6,086,957$11.54204.77view
Nohria VirinderDirector 2014-11-13Sell2,000,000$11.54204.77view
Kelly David GeorgeEVP & Corporate Secretary 2014-11-06Sell0$0204.77view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice o Jul 31 2015 
Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
Horizon Pharma plc Announces Collaboration With Fox Chase Cancer Center to Study ACTIMMUNE(R) (inter Jul 27 2015 
Horizon Pharma plc Increases Offer for Depomed, Inc. to $33.00 per Share Jul 21 2015 
Horizon Pharma plc Expects Record Net Sales Results for Second Quarter 2015 and Raises Full-Year 201 Jul 20 2015 
Horizon Pharma plc Responds to Depomed's Adoption of a Poison Pill Jul 13 2015 
Horizon Pharma plc Files Patent Infringement Lawsuits Against Five Companies for Filing Abbreviated Jul 06 2015 
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice o Jul 02 2015 
hznp May 24 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 

More From Other Websites
Horizon Sues to Knock Out Depomed’s Poison Pill Takeover Defense Aug 03 2015
More Pharma Buyouts Ahead? 3 Top Stocks In Buy Range Aug 03 2015
Horizon asks for Depomed vote, files lawsuit in hostile bid Aug 03 2015
Horizon asks for Depomed vote, files lawsuit in hostile bid Aug 03 2015
Depomed Comments on Horizon Pharma Announcement Aug 03 2015
Is a Vote on Depomed Takeover on the Horizon? Aug 03 2015
Depomed Comments on Horizon Pharma Announcement Aug 03 2015
Horizon Pharma Pressures Depomed to Let Investors Vote on Offer Aug 03 2015
Early movers: GS, PRE, SHLD, HZNP, TSN, T & more Aug 03 2015
Horizon Pharma plc Commences Process to Request a Special Meeting of Depomed, Inc. Shareholders Aug 03 2015
HORIZON PHARMA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 03 2015
Depomed Holder Horizon Pharma Files Solicitation Statement Aug 03 2015
Horizon Pharma plc Commences Process to Request a Special Meeting of Depomed, Inc. Shareholders Aug 03 2015
5 Under-the-Radar Growth Stocks to Buy Now Aug 02 2015
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Jul 31 2015
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Jul 31 2015
Will Q2 Earnings Wake Up Jazz Pharma's Stock? Jul 30 2015
Will Jazz Pharma's Stock Awake With Q2 Earnings? Jul 30 2015
Depomed Rejected Horizon Pharma's Takeout Bid, But Still Trades As If M&A Is Happening Jul 30 2015
Ahead of the Bell: Depomed rejects Horizon offer Jul 30 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK